GB1591365A - Aerosol package - Google Patents

Aerosol package Download PDF

Info

Publication number
GB1591365A
GB1591365A GB667079A GB667079A GB1591365A GB 1591365 A GB1591365 A GB 1591365A GB 667079 A GB667079 A GB 667079A GB 667079 A GB667079 A GB 667079A GB 1591365 A GB1591365 A GB 1591365A
Authority
GB
United Kingdom
Prior art keywords
package
valve
orifice
composition
aerosol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB667079A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unilever PLC
Original Assignee
Unilever PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever PLC filed Critical Unilever PLC
Priority to GB667079A priority Critical patent/GB1591365A/en
Publication of GB1591365A publication Critical patent/GB1591365A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00Anti-perspirants or body deodorants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/046Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26Aluminium; Compounds thereof
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K3/00Materials not provided for elsewhere
    • C09K3/30Materials not provided for elsewhere for aerosols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41Particular ingredients further characterized by their size
    • A61K2800/412Microsized, i.e. having sizes between 0.1 and 100 microns
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/87Application Devices; Containers; Packaging

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)

Description

(54) AEROSOL PACKAGE (71) We, UNILEVER LIMITED, a British company, of Unilever House, Blackfriars, London EC4, England, do hereby declare the invention for which we pray that a patent may be granted to us and the method by which it is to be performed, to be particularly described in and by the following statement:- This invention relates to an aerosol package including in combination an aerosol powder spray composition comprising an active ingredient in finely divided form suspended in a liquid phase comprising propellant liquid and a carrier liquid, and a container fitted with a discharge spray valve. When the actuator or button of the valve is operated the composition is discharged in aerosol form through the outlet or terminal orifice, which is usually in the actuator, by the pressure of the propellant vapour within the container. Many marketed antiperspirant aerosol products are of the above type at the present time.
When a composition is discharged as an aerosol from a pressurised pack some of the aerosol particles may be inhaled by the user or by other persons in the vicinity. The proportion of the product discharged which is capable of reaching and being deposited in the lung is called herein the "respirable fraction" of the product.
Industry is concerned that the user should not be exposed unnecessarily to respirable particles. This invention is concerned with the reduction of the respirable fraction of aerosol powder spray products.
The present invention is based upon our finding that improved aerosol packages which give rise to sprays having reduced respirable fractions can be produced by selecting particular combinations of certain parameters or factors of the aerosol package, said parameters or factors being the pressure within the aerosol container, the area of the terminal or outlet orifice, the ratio of the area of any vapour tap orifice of the valve and either the area of the valve tail piece orifice or the bore of the dip tube of the valve, whichever is the smaller, and the sedimentation volume (as hereinafter defined) of the composition.
Accordingly, the present invention provides a package for containing and dispensing a powder including in combination a container having an aerosol spray valve for dispensing liquid in aerosol form and a composition within the container consisting of a powder suspended in a liquid vehicle comprising a mixture of a liquid carrier and a liquefied propellant, the package satisfying the following conditions: (B) the valve has a terminal orifice having an area of at least 3 x 10-4 sq in; (C) the ratio of the area of any vapour tap orifice of the valve and either the valve tail piece orifice or the bore of the valve dip tube, whichever is the smaller, is not more than 0.05; and (D) the sedimentation volume of the composition (as herein defined) is at least 40%.
Psig stands for pounds per square inch gauge.
The sedimentation volume of the composition is to be understood to mean that volume occupied by the powder after shaking and allowing the composition to stand for 24 hours expressed as a percentage of the total volume of the composition, In practice the sedimentation volume is determined by packaging the composition in a container of transparent material and expressing the sedimental height after 24 hours as a percentage of the total height of the composition.
For a discussion of the construction of aerosol valves reference is made to chapter 6 of "Principles of Aerosol Technology" by Paul A. Sanders (1970).
While the actuator may be a standard actuator or a mechanical breakup actuator, the standard actuator is preferred. The upper limit of the area of the terminal orifice of the valve is not critical but will be limited in practice by the desired spray characteristics of the valve. In the usual case of the terminal orifice being in the actuator, the upper limit of orifice area may also be limited by the finite size of the actuator. Usually the area of the terminal orifice will be in the range from 3 x 10-4 to 12 x 10-4 sq ins, being preferablY at least 4.5 x 10-4 sq ins.
With a valve fitted to a standard dip tube (usually of internal diameter 0.150 inches) which fits over the end of the tail piece the area of the tail piece orifice will be smaller than the cross-sectional area of the bore of the dip tube. In the case of a capillary dip tube (usually of internal diameter of 0.060 inches or less), which is fitted within the tail piece, the ratio in condition C above is determined by the area of the bore of the dip tube or the area of any restricted orifice within the tail piece, whichever is the smaller.
Aluminium chlorhydrate is the most widely used antiperspirant active material at the present time but other antiperspirants can be used in the aerosol package of this invention. Such other suitable materials are well known and include those referred to in British Patent Specifications Nos. 1,393,860, 1,353,916,1,343,653, United States Patent Specifications Nos. 3,792,068, 3,726,968 and 3,903,258 and Netherlands Patent Application No. 7,601,377.
Although current commercial grades of aluminium chlorhydrate have weight average particle sizes in the range 10 to 25 microns, they will include a fraction having a particle size below 7 microns. We have surprisingly found that the inhalable fraction decreases as the weight percentage of the powder less than 7 microns increases. Antiperspirant materials widely used at the present time comprise particles at least 25% (by number) of which have a size in the range 0 to 6 microns and the present invention is especially applicable to products containing these materials although, of course, it is by no means restricted to the use of such materials.
Although this invention has particular applicability to antiperspirant aerosol powder sprays, the powder may be other than an antiperspirant powder since the nature of the powder is not critical to the invention. A number of powders which can be used in aerosol powder sprays are mentioned in an article by S. C. Elvin entitled "Powder Aerosols" in Aerosol Age, September 1971, page 26.
Furthermore, the powder may be a moisture absorbent organic polymer, especially one having a capacity for absorbing an amount of moisture at least equal to its own weight. Such polymers are described in British Patent Specification No.
1,485,373.
Further examples of powders which may be employed in the package of the invention are those ahving deodorant properties, for example sodium bicarbonate, sodium carbonate and hexachlorophene.
Mixtures of powders may also be used.
The amount of powder present in the composition may vary over a wide range but will usually be in the range 1 to 25% by weight of the composition. In the case of antiperspirant powders the amount will preferably be from 1% to 10% by weight of the composition, particularly 2% to 7% by weight.
The powder is suspended in a liquid vehicle comprising a mixture of a liquid carrier and a liquefied propellant. Such mixtures are conventional in the art and many materials which may be used have been suggested.
The carrier liquid may for example be a non-volatile non-hygroscopic liquid as suggested in US Patent No. 3,968,203. Especially useful are carrier liquids which have emollient properties and a number of these are referred to in British Patent Specification No. 1,393,860. Especially preferred are fatty acid esters such as isopropyl myristate and those esters referred to in US Patent Specification No.
4,045,548 such as dibutyl phthalate and diisopropyl adlpate.
Various other carrier liquids for powder suspension aerosols are suggested in US Patent Specifications Nos. 3,974,270, 3,949,066, 3,920,807, 3,833,721 and 3,833,720 and in British Patent Specifications Nos. 1,411,547, 1,369,872, 1,341,748 and 1,300,260. Volatile carrier liquids may also be used such as ethanol as described in South African Patent Specification No. 75/3576, and volatile silcones as described in British Patent Specification No. 1,467,676.
The ratio of total solids in the compositions to the carrier liquid may vary over a wide range, for example from 0.01 to 3 parts of the powder per part by weight of the carrier liquid.
The liquefied propellant can be a hydrocarbon, a halogenated hydrocarbon or a mixture thereof. Examples of materials that are suitable for use as propellants are given in the above-mentioned patents and include trichlorofluoromethane, dichlorodifluoromethane, dichdlorotetrafluoroethane, monochlorodifluoromethane, trichlorotrifluoroethane, propane, butane, 1,1 -difluoroethane, 1,1 - difluoro- 1 -chloroethane, dichloromonofluoromethane, methylene chloride, and isobutane, used singly or admixed. Trichlorofluoromethane, dichlorodifluoromethane, dichlorotetrafluoroethane, and isobutane, used singly or admixed, are preferred. The propellant or propellant blend is preferably chosen so as to give a pressure within the aerosol container of from 5 to 30 psig at 200 C, more preferably 15 to 30 psig.
It is common practice to include in aerosol powder spray compositions a material to assist in the suspending of the powder in the liquid vehicle. The materials prevent compacting of the powder and they may also act as thickening or gelling agents for the liquid vehicle. Especially preferred are hydrophobic clays and colloidal silicas. Hydrophobic clays are available under the trade mark Bentone, e.g. Bentone-34 or Bentone-38, and their use as suspending agents as described in a number of patent specifications including US Patent Specification No. 3,773,683.
Suitable colloidal silicas include Aerosil 200 and Cab-O-Sil M-5 as well as other grades: the words Aerosil and Cab-O-Sil are trade marks.
In the package of the present invention the suspending agent in the liquid vehicle imparts a sedimentation volume to the composition of at least 40%, preferably at least 50%. This sedimentation volume can be obtained by the choice of an appropriate amount of suspending agent and by using high shear mixing conditions for the incorporation of the suspending agent. The amount of the suspending agent may range from 0.1 to 2% by weight of the composition.
Various minor optional ingredients may also be included such as perfumes.
The respirable fraction of the particles produced by an aerosol pack was determined in the following experiments using an Hexhlet elutriator (Brit. J. industr. Med., 1954, 11, 284) which separates particles according to their falling velocities in the air. The aerosol is drawn at a controlled horizontal velocity through a parallel plate elutriator; the vertical spacing of the plates is such that particles settling on them during the transit of the aerosol through the elutriator correspond to those which would separate aerodynamically in the upper respiratory tract of man. Thus the particles passing through the elutriator and collected on a filter represent those which would penetrate to the human lungs.
The upper aerodynamic size limit for respirable particles collected in the Hexhlet is about 7 microns.
The procedure was as follows. A filter, dried and weighed, was loaded into the Hexhlet sampler and the pressurised pack to be tested was weighed. The vacuum was adjusted so that the gauge on the Hexhlet showed about 300 mm Hg. After thorough shaking, the aerosol was sprayed into a cabinet fitted to the front of the Hexhlet sampler, each spray was of 2 seconds duration, the sprays being repeated with shaking every 20 seconds for a total of 20 sprays. Sampling was continued for 5 minutes after the last spray. The pack was re-weighed to give the weight of product discharged. The filter was removed and heated at 500C for 24 hours and then reweighed. In this way the weight of non-volatiles collected was determined and this weight is expressed in milligrams per 100 g of product discharged. This weight is a measure of the respirable non-volatiles in an aerosol cloud and will be referred to hereinafter by the letters NVRF (standing for non-volatile respirable fraction). The use of the Hexhlet in determining respirable fractions is also described in Aerosol Age, Volume 21, No. 11, November 1976, pages 20 to 25.
Experiments will now be described illustrating the effect of the above parameters on the non-volatile respirable fraction of an aerosol spray.
In the experiments described hereinafter a standard package employed contained an aerosol powder spray composition of the following formula, all percentages herein being by weight unless specified otherwise: Aluminium chlorhydrate powder (MICRO-DRY) 4.5u Isopropyl myristate 6.00 Pyrogenic silica (AEROSIL 200) 0.45 Perfume 0.44 Propellant (50:50 mixture of propellants I I and 12) to 100.00 (Propellant 11 is trichlorofluoromethane) (Propellant 12 is dichlorodifluoromethane) The concentrate, i.e. the mixture of the aluminium chlorhydrate, isopropyl myristate, pyrogenic silica and perfume, was mixed with part of the propellant and then subjected to high shear in a mixer for 20 minutes. The remainder of the propellant was then added and the resulting composition then filled into an aerosol can.
This composition gave a pressure in the container of 41 psig at 230C. It had a sedimentation volume of 50%. The valve had a vapour tap whose orifice was 0.020 inch in diameter and the diameter of the tail piece orifice was 0.080 inch. The valve was fitted with an actuator having a terminal orifice of diameter 0.020 inch. A standard dip tube of internal diameter 0.15 inch was fitted to the valve.
In the experiments described hereinafter one or more of the above parameters was varied to show the effect of such variation on the respirable fraction of the aerosol cloud produced by the aerosol package.
Experiments showing the effect of can pressure on the respirable fraction of an aerosol powder spray were conducted on the above standard formulations save that the ratio of propellants 11 and 12 was varied to give a range of vapour pressures within the can. The package also differed from the above in that the diameter of the vapour tap orifice was 0.013 inch. The results are given in Table 1.
TABLE I Can Pressure at 23"C (psig) NVRF 37 120 32 67 31 46 24 17 19 1 The results given in Table 11 below show the effect of the size of the actuator terminal orifice on the non-volatile respirable fraction (NVRF).
TABLE II Actuator Terminal Orifice Diameter (thousandths of an inch) NVRF 13 346 15 330 18 209 20 183 25 115 30 97 40 73 Experiments have also been conducted showing the effect of reducing the ratio of the areas of the vapour tap orifice and tail piece orifice from 0.06 to zero through the use of valves having vapour tap orifices of 0.020 inch, 0.013 inch and using a valve with no vapour tap. The results of the experiments are shown in Tables III and IV. The results in Tables III and IV were obtained using blends of propellants 11 and 12, giving can pressures of about 30 and 25 psig at 230C, respectively.
TABLE III Vapour Tap Diameter (thousandths of an inch) NVRF 20 58 13 46 0 19 TABLE IV Vapour Tap Diameter (thousandths of an inch) NVRF 20 54 13 17 0 8 In experiments illustrating the finding that products with increasing sedimentation volumes result in aerosol sprays with a lower respirable fraction, there were employed a number of compositions which were obtained by varying the level of the pyrogenic silica in the above composition between 0.20 and 0.60 weight percent.
The results obtained are given in Table V.
TABLE V Sedimentation Volume ( /O) NVRF 35 283 43 252 56 211 61 194 65 192 In Tables I, III and IV the NVRF values are generally lower than those in Tables II and V. This is because the series of experiments summarised in Tables I, III and IV were carried out at a time when the ambient temperature in the laboratory was substantially lower. The actual NVRF value obtained with a given aerosol package is dependent somewhat on the ambient temperature at which the determination is carried out.
The results of further experiments showing the cumulative effect on the respirable fraction of a decrease in can pressure, reduction in the ratio of the areas of the vapour tap and tail piece orifices, and increase in sedimentation volume are shown in Table VI.
TABLE VI
Area Vapour Tap Orifice Can Pressure at Sedimentation 23 C (psig) Area Tail Piece Orifice Volume (%) NVRF 35 251 0.0625 76 244 37 35 185 zero 76 154 35 60 0.0625 76 47 35 23 zero 76 16 The cumulative effect of increase in the area of the actuator orifice and decrease in can pressure is shown in Table VII. In these experiments the vapour tap orifice had a diameter of 0.013 inch.
TABLE VII
Diameter of Actuator Can Pressure Terminal Orifice at 230C (psig) NVRF 30 46 0.020 inch 25 17 30 23 0.035 inch 25 7 In experiments to determine the effect on the respirable fraction of using powders containing differing numbers of particles of respirable size, three different commercial grades of aluminium chlorhydrate were used. The materials employed were those manufactured by the Reheis Chemical Company and sold as the "MICRO-DRY", "MICRO-DRY Ultrafine" and "Microspherical" grades, respectively, of "CHLORHYDROL". (CHLORHYDROL and MICRO-DRY are trademarks.) Samples of these materials were examined by means of a scanning electronmicroscope and the weight and number percentages of the particles found in the 0-6 microns range are given in Table VIII.
TABLE VIII Weight Percentage Number Percentage Aluminium in Size Range in Size Range Chlorhydrate e6 microns 0-6 microns MICRO-DRY Ultrafine 2.0 56 MICRO-DRY 1.4 35 Microspherical 0.4 20 Respirable fraction data using these different materials in a commercial product (differing from the above standard product and containing 3.5% aluminium chlorhydrate and 3.0% isopropyl myristate) are given in Table IX.
TABLE IX Aluminium chlorhydrate NVRF MICRO-DRY Ultrafine 131 MICRO-DRY 135 Microspherical 185 It was shown in other experiments that the relatively high NVRF value for the product employing aluminium chlorhydrate having the least number of particles below 6 microns was not due to any breakdown of the particles, it being noted that these particles are in the form of hollow spheres. These further experiments involved use of zero shear and 50 minute shearing of the product concentrate in the processing stage and examination of the sprayed product by scanning electron microscopy. No sign of breakdown was observed. Although the product containing the least number of particles of aluminium chlorhydrate below 6 microns gave the highest respirable fraction, it has also been shown that for that product the proportion of the respirable material which was aluminium chlorhydrate was the least of the three products. Even if all the particles of the powder were to be above the respirable size, use of the combinations of conditions in accordance with the invention would still be useful for reducing the respirable fraction, which would in such a case consist mainly of the carrier liquid.
The following Table X illustrates examples of packages in accordance with the invention and Tables XI and XII show typical formulae for the aerosol composition for use in such packages.
TABLE X The composition: suspension of a powder, especially an antiperspirant material, in a liquid vehicle comprising a carrier liquid and a liquefied propellant
Vapour Tap Tail Piece Actuator Terminal Orifice Orifice Can Pressure Orifice Diameter Diameter Diameter Sedimentation Example (psig at 200C (inches) (inches) (inches) Volume (to) 1 37 0.030 0 0.080 60 2 40 0.030 0.013 0.080 40 3 25 0.030 0 0.080 60 4 28 0.025 0.013 0.080 50 TABLE XI Composition: A B C D E F G H Aluminium chlorhydrate 5.0 - - 3.0 2.0 3.1 4.5 3.5 ZAG - 7.0 3.5 - - - - Isopropyl myristate - - 8.0 - 6.0 - 6.0 1.0 Di-n-butyl phthalate 3.0 - - - - - - Diisopropyl adipate - 3.5 - 0.5 - - - Isopropyl palmitate - - - 0.5 - - - Hexylene glycol - - - - - 1.8 - Volatile silicone - - - - - - - 5.0 Pyrogenic silica qs - - - - qs qs qs Bentone-38 qs qs qs qs qs - - Propylene carbonate qs qs qs qs qs - - Perfume 0.3 0.3 0.4 0.2 - 0.4 0.4 Blend4 Propellants 11 & 12 qs - qs qs qs qs qs qs Blend4 Propellant 114: - qs - - - - - isobutane:Propellant 12 Zirconyl hydroxychloride:aluminium hydroxychloride:glycine complex (7.5:4.6:2) An appropriate amount is used to give the desired sedimentation volume as indicated in Table X.
Used in an amount of 0.33 by weight of the Bentone.
4 The balance of the composition is an appropriate blend to give the desired can pressure as indicated in Table X.
TABLE XII Composition: I J K Sodium bicarbonate 3.0 ~ ~ Hexachlorophene - 0.3 Microcrystalline cellulose (AVICEL RC581) ~ ~ 3.0 Isopropyl myristate - 4.0 3.0 Isopropyl palmitate 6.5 Pyrogenic silica2 qs qs qs Perfume 0.2 1.0 0.2 Blend4 of Propellants 11 and 12 qs qs qs 2 See Table XI.
4 See Table XI.
Further examples of packages in accordance with the invention are given in Table XIII.
TABLE XIII Example 5 6 7 Ingredients of Composition Aluminium chlorhydrate (MICRO-DRY) - 4 DO 4.00 Starch powder 3.50 Sodium carbonate 0.25 Isopropyl myristate 3.50 8.00 8.00 Polyoxyethylene polyoxypropylene block 0.50 copolymer (PLURONIC L62D) Pyrogenic silica (AEROSIL 200) - - OA0 Bentone-38 0.60 0.60 Alcohol/water mixture (95 : 5) 0.30 0.30 Perfume 0.44 0.50 0.44 Blend of Propellants 11 and 12 (70:30) to 100.00 to 100.00 to 100.00 TABLE XIII (Continued) Example Details of Package 5 6 7 Pressure at 230C (psig) 27 27 27 Actuator terminal orifice diameter (inches) 0.030 0.020 0.035 Vapour tap orifice diameter (inches) 0.013 0.013 0.013 Tail piece orifice diameter (inches) 0.080 0.080 0.080 Dip tube diameter (inches) 0.150 0.150 0.150 Sedimentation volume (%) 40 70 45 NVRF 30 61 24 The words AVICEL and PLURONIC in Tables XII and XIII, respectively, are trade marks.
In application No. 44878/76 there is described and claimed a package for containing and dispensing a powder including in combination a container having an aerosol spray valve for dispensing liquid in aerosol form and a composition within the container consisting of a powder suspended in a liquid vehicle comprising a mixture of a liquid carrier and a liquefied propellant, the packages being such that of the following conditions: (A) the vapour pressure within the container is from 5 to 30 psig at 200 C; (B) the valve has a terminal orifice having an area of at least 3 x 10-4 sq in; (B') the valve has a terminal orifice having an area of at least 4.5 x 10-4 sq in; (C) the ratio of the area of any vapour tap orifice of the valve and either the valve tail piece orifice or the bore of the valve dip tube, whichever is the smaller, is not more than 0.05; and (D) the sedimentation volume of the composition is at least 40%; there is satisfied the combination of condition A with any one of conditions B', C and D; or the combination of condition A with at least two of conditions B, C and D.

Claims (9)

WHAT WE CLAIM IS:
1. A package for containing and dispensing a powder including in combination a container having an aerosol spray valve for dispensing liquid in aerosol form and a composition within the container consisting of a powder suspended in a liquid vehicle comprising a mixture of a liquid carrier and a liquefied propellant, the package satisfying the following conditions: (B) the valve has a terminal orifice having an area of at least 3 x 10-4 sq in; (C) the ratio of the area of any vapour tap orifice of the valve and either the valve tail piece orifice or the bore of the valve dip tube, whichever is the smaller, is not more than 0.05; and (D) the sedimentation volume of the composition (as herein defined) is at least 40%.
2. A package as claimed in claim 1, wherein the valve has a terminal orifice having an area of at least 4.5 x 10-4 sq in.
3. A package as claimed in claim I or claim 2, wherein the valve has no vapour tap orifice.
4. A package as claimed in any of claims I to 3, wherein the sedimentation volume of the composition is at least 50%.
5. A package as claimed in any of claims 1 to 4, wherein the powder is an antiperspirant active material.
6. A package as claimed in claim 5, wherein the antiperspirant active material is aluminium chlorhydrate.
7. A package as claimed in claim 6, wherein the aluminium chlorhydrate is such that 25% or more by number of the particles have a size in the range 0 to 6 microns.
8. A package substantially as herein described with reference to Example I or Example 2.
9. A package as claimed in claim 8 comprising a composition substantially as described with reference to any of Compositions A to K.
GB667079A 1977-10-27 1977-10-27 Aerosol package Expired GB1591365A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB667079A GB1591365A (en) 1977-10-27 1977-10-27 Aerosol package

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB667079A GB1591365A (en) 1977-10-27 1977-10-27 Aerosol package

Publications (1)

Publication Number Publication Date
GB1591365A true GB1591365A (en) 1981-06-17

Family

ID=9818677

Family Applications (1)

Application Number Title Priority Date Filing Date
GB667079A Expired GB1591365A (en) 1977-10-27 1977-10-27 Aerosol package

Country Status (1)

Country Link
GB (1) GB1591365A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2858492B1 (en) 2012-06-08 2016-09-21 S.C. Johnson & Son, Inc. Spray formulations with reduced clogging/sedimentation characteristics

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2858492B1 (en) 2012-06-08 2016-09-21 S.C. Johnson & Son, Inc. Spray formulations with reduced clogging/sedimentation characteristics

Similar Documents

Publication Publication Date Title
US3088874A (en) Powder aerosol
US5334374A (en) Pharmaceutical compositions containing pentamidine
US5605682A (en) Antiperspirant aerosol composition with high solids content
HU208398B (en) Process for producing pharmaceutical aerosol composition
NO325491B1 (en) Product for dispensing pharmaceutical aerosol formulations
US3773683A (en) Novel suspending agent composition for use in powder aerosol compositions and process for preparation
CA2014401A1 (en) Aerosolised azole anti fungals
EP0674899B1 (en) Deodorant compositions
CA2106137C (en) High efficacy aerosol antiperspirant composition
US4431120A (en) Packaging system
WO2004014330A1 (en) Antiperspirant aerosol compositions
JPH02255889A (en) Aerosol composition
GB1591312A (en) Aerosol package
US5156833A (en) Powder aerosol composition
GB1591365A (en) Aerosol package
JP3785664B2 (en) Antiperspirant spray composition
MXPA01005471A (en) Milling process for the production of finely milled medicinal substances.
JP2772073B2 (en) Powder aerosol composition
WO1996018378A2 (en) Single phase aerosol antiperspirant composition
US3863005A (en) Dual astringent composition
Sciarra Pharmaceutical and cosmetic aerosols
CA1072507A (en) Hairsprays
JPS63141910A (en) Aerosol composition for body lotion
EP3558228B1 (en) Anhydrous antiperspirant aerosol composition
JP3035632B2 (en) Powder aerosol cosmetics

Legal Events

Date Code Title Description
PS Patent sealed
PE20 Patent expired after termination of 20 years

Effective date: 19971026